Schedule 13G ownership disclosure

BioMarin Pharmaceutical Inc

COM · CUSIP: 09061G101

Event date: 2025-06-30

Filing-level shares
15,795,383
Percent of class
8.24%
  • PRIMECAP MANAGEMENT CO/CA/

    Shares: 15,795,383 · Class: 8.24%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-25-005169
Form type
SCHEDULE 13G/A
Filer
BIOMARIN PHARMACEUTICAL INC
CIK
CIK 1048477
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub